Table 1.
1. Pulmonary arterial hypertension (PAH) |
1.1 Idiopathic (IPAH) |
1.2 Familial (FPAH) |
1.3 Associated with (APAH): |
1.3.1 Collagen vascular disease |
1.3.2 Congenital systemic-to-pulmonary shunts |
1.3.3 Portal hypertension |
1.3.4 HIV infection |
1.3.5 Drugs and toxins |
1.3.6 Other (thyroid disorders, glycogen storage disease, Gaucher disease, hereditary hemorrhagic telangiectasia, hemoglobinopathies, myeloproliferative disorders, splenectomy) |
1.4 Associated with significant venous or capillary involvement |
1.4.1 Pulmonary veno-occlusive disease (PVOD) |
1.4.2 Pulmonary capillary hemangiomatosis (PCH) |
1.5 Persistent pulmonary hypertension of the newborn |
2. Pulmonary hypertension with left heart disease |
2.1 Left-sided atrial or ventricular heart disease |
2.2 Left-sided valvular heart disease |
3. Pulmonary hypertension associated with lung diseases and/or hypoxemia |
3.1 Chronic obstructive pulmonary disease |
3.2 Interstitial lung disease |
3.3 Sleep-disordered breathing |
3.4 Alveolar hypoventilation disorders |
3.5 Chronic exposure to high altitude |
3.6 Developmental abnormalities |
4. Pulmonary hypertension due to chronic thrombotic and/or embolic disease |
4.1 Thromboembolic obstruction of proximal pulmonary arteries |
4.2 Thromboembolic obstruction of distal pulmonary arteries |
4.3 Non-thromboembolic pulmonary embolism (tumor, parasites, foreign material) |
5. Miscellaneous |
Sarcoidosis, histiocytosis X, lymphangiomatosis, compression of pulmonary vessels (adenopathy, tumor, fibrosing mediastinitis) |
Abbreviations: HIV, human immunodeficiency virus.